GURUFOCUS.COM » STOCK LIST » Technology » Software » Clarivate PLC (NYSE:CLVT) » Definitions » Intrinsic Value: Projected FCF

Clarivate (Clarivate) Intrinsic Value: Projected FCF : $0.00 (As of Apr. 26, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Clarivate Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-26), Clarivate's Intrinsic Value: Projected FCF is $0.00. The stock price of Clarivate is $7.12. Therefore, Clarivate's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Clarivate's Intrinsic Value: Projected FCF or its related term are showing as below:

CLVT's Price-to-Projected-FCF is not ranked *
in the Software industry.
Industry Median: 1.59
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Clarivate Intrinsic Value: Projected FCF Historical Data

The historical data trend for Clarivate's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarivate Intrinsic Value: Projected FCF Chart

Clarivate Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial - - - - -

Clarivate Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Clarivate's Intrinsic Value: Projected FCF

For the Information Technology Services subindustry, Clarivate's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clarivate's Price-to-Projected-FCF Distribution in the Software Industry

For the Software industry and Technology sector, Clarivate's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Clarivate's Price-to-Projected-FCF falls into.



Clarivate Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Clarivate  (NYSE:CLVT) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Clarivate's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=7.12/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clarivate Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Clarivate's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Clarivate (Clarivate) Business Description

Industry
Traded in Other Exchanges
Address
70 St. Mary Axe, London, GBR, EC3A 8BE
Clarivate PLC is an information, analytics, and workflow solutions company. It operates in three segments: Academia and Government; Life Sciences and Healthcare and Intellectual Property. The company generates maximum revenue from the Academia and Government segment. The A&G segment consists of Academia and Government product group, which drives research excellence across institutions, empower researchers to tackle today's global challenges and help academic institutions and libraries improve operational efficiency and effectiveness. Geographically, it derives a majority of its revenue from the Americas.
Executives
Melanie Margolin officer: Chief Legal Officer 1000 SAGAMORE PARKWAY SOUTH, LAFAYETTE IN 47905
Saurabh Saha director C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT
Henry Levy officer: President, LS&H 70 ST. MARY AXE, LONDON X0 EC3 8BA
Bar Veinstein officer: President, A&G 70 ST. MARY AXE, LONDON X0 EC3 8BA
James Gordon Samson officer: President, IP Group FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE 1 8EZ
Andrew Miles Snyder director 111 WEST 57TH STREET, 9TH FLOOR, NEW YORK NY 10019
Wendell E. Pritchett director TOLL BROTHERS, INC., 1140 VIRGINIA DRIVE, FORT WASHINGTON PA 19034
Jonathan Gear director, officer: Chief Executive Officer-Elect C/O IHS MARKIT LTD., 4TH FLOOR, ROPEMAKE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Michael M Easton officer: Senior VP, Finance/CAO 4TH FLOOR ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Stefano Maestri officer: Chief Technology Officer 70 ST MARY AXE, LONDON X0 EC3 8BA
Jonathan Mark Collins officer: Executive Vice President/CFO 50196 VENICE COURT, NORTHVILLE MI 48168
Mukhtar Ahmed officer: President, Science Group FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Michael J Angelakis director 40 MORRIS AVENUE, BRYN MAWR PA 19010
Heather Matzke-hamlin officer: Acting Chief Acctg Officer 4TH FLOOR, ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Steen Lomholt-thomsen officer: Chief Revenue Officer FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE1 8EZ